Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medplus Health ServicesNSE:MEDPLUS +0.75%85 3-Year ROIIC % is 22.39 as of Mar. 2026, which is 190% above its 10-year median of 7.72. GuruFocus rates NSE:MEDPLUS with a GF Score™ of 85/100 and a GF Value™ of ₹959.61 (Modestly Undervalued). Among 620 Healthcare Providers & Services companies, Medplus Health Services ranks better than 74.03% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Medplus Health Services's 3-Year ROIIC % for the quarter that ended in Mar. 2026 was 22.39%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Medplus Health Services's 3-Year ROIIC % or its related term are showing as below:
NSE:MEDPLUS's 3-Year ROIIC % is ranked better than 74.03% of 620
companies
in the Healthcare Providers & Services industry
Industry Median: 3.37
vs NSE:MEDPLUS: 22.39
Medplus Health Services (NSE:MEDPLUS) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Medplus Health Services 3-Year ROIIC % Related Terms
Medplus Health Services 3-Year ROIIC % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medplus Health Services 3-Year ROIIC % Competitor Comparison
For the Pharmaceutical Retailers subindustry, Medplus Health Services's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medplus Health Services 3-Year ROIIC % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Medplus Health Services's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Medplus Health Services's 3-Year ROIIC % falls into.
Medplus Health Services 3-Year ROIIC % Calculation
Medplus Health Services's 3-Year ROIIC % for the quarter that ended in Mar. 2026 is calculated as:
3-Year ROIIC %
=
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( 2597.50404 (Mar. 2026) - 873.32 (Mar. 2023) )
/
( 29501.45 (Mar. 2026) - 21799.08 (Mar. 2023) )
=
1724.18404
/
7702.37
=
22.39%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Medplus Health Services (NSE:MEDPLUS) has a 3-Year ROIIC % of 22.39 as of Mar. 2026. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Medplus Health Services and its competitors. This is 190% above median its historical median of 7.72. Over the past decade, Medplus Health Services' 3-Year ROIIC % has ranged from 2.49 to 22.39. According to the industry distribution chart, Medplus Health Services ranks #161 out of 620 companies in the Healthcare Providers & Services industry, placing it in the top 26%.
Is Medplus Health Services' 3-Year ROIIC % too high?
Medplus Health Services' current 3-Year ROIIC % of 22.39 is 190% above median its 10-year median of 7.72. Over the past 10 years, this metric has ranged from a low of 2.49 to a high of 22.39. The Healthcare Providers & Services industry median 3-Year ROIIC % is 3.37. Medplus Health Services' value of 22.39 is 564.4% above this industry median. Based on the distribution chart, Medplus Health Services ranks #161 out of 620 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Medplus Health Services has a GF Score™ of 85/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medplus Health Services' 3-Year ROIIC % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Medplus Health Services ranks #161 out of 620 companies for 3-Year ROIIC %. This puts Medplus Health Services in the upper half of its industry. The industry median 3-Year ROIIC % is 3.37. Medplus Health Services' value of 22.39 is 564.4% above this benchmark. Historically, Medplus Health Services' own 3-Year ROIIC % has ranged from 2.49 to 22.39 over the past decade. While the company's 10-year median is 7.72 vs. the industry median of 3.37, Medplus Health Services has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Healthcare Providers & Services company?
The median 3-Year ROIIC % among Healthcare Providers & Services companies is 3.37, based on 620 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medplus Health Services's current 3-Year ROIIC % of 22.39 is 564.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Medplus Health Services and its competitors. For the Healthcare Providers & Services industry, the median 3-Year ROIIC % is 3.37 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medplus Health Services's current 3-Year ROIIC % is 22.39, which is 190% above median its own 10-year median of 7.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medplus Health Services stock overvalued right now?
Based on GuruFocus' analysis, Medplus Health Services (NSE:MEDPLUS) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹959.61, compared to a current price of ₹720.55 — trading 24.9% below its estimated fair value. The current 3-Year ROIIC % is 22.39, which is 190% above median its 10-year median of 7.72 and 564.4% above the Healthcare Providers & Services industry median of 3.37. Medplus Health Services' overall GF Score™ is 85/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Medplus Health Services (NSE:MEDPLUS), the current 3-Year ROIIC % is 22.39 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medplus Health Services (NSE:MEDPLUS) Overvalued in 2026?
Based on GuruFocus' analysis, Medplus Health Services stock appears to be undervalued.
The current stock price of ₹720.55 is trading 24.9% below its estimated GF Value™ of ₹959.61.
GuruFocus considers Medplus Health Services to be Modestly Undervalued.
Key valuation signals for NSE:MEDPLUS:
3-Year ROIIC %: 22.39 (190% above median its 10-year median of 7.72)
GF Value™: ₹959.61 vs. price of ₹720.55 (24.9% below fair value)
Industry Position: 564.4% above the Healthcare Providers & Services median (#161 of 620)
No single metric tells the full story. See the NSE:MEDPLUS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medplus Health Services Ltd is a pharmacy retailer. It offers pharmaceutical and wellness products such as medicines, vitamins, medical devices, test kits, and others. The company also offers an omnichannel platform wherein customers can purchase products through stores, place orders over the telephone, online orders, and a Click and Pick facility. Its operating segments include Retail, Diagnostics, and Others.
85GF Score
Get the complete analysis for NSE:MEDPLUS
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:MEDPLUS has been successfully added to your 
